215 related articles for article (PubMed ID: 34578755)
21. Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model.
Abd El-Aziz FEA; Hetta HF; Abdelhamid BN; Abd Ellah NH
Nanomedicine (Lond); 2022 Mar; 17(6):353-365. PubMed ID: 35184603
[No Abstract] [Full Text] [Related]
22. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
23. Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy.
Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Amir M; Sarafroz M
Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32120778
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
[TBL] [Abstract][Full Text] [Related]
25. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
26. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
27. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
28. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
29. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
30. An antibacterial nanoclay- and chitosan-based quad composite with controlled drug release for infected skin wound healing.
Wei W; Wang M; Liu Z; Zheng W; Tremblay PL; Zhang T
Carbohydr Polym; 2024 Jan; 324():121507. PubMed ID: 37985094
[TBL] [Abstract][Full Text] [Related]
31. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer.
Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T
Front Chem; 2023; 11():1044953. PubMed ID: 36846852
[TBL] [Abstract][Full Text] [Related]
32. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
Dhal C; Mishra R
Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
[TBL] [Abstract][Full Text] [Related]
33. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].
Pan Y; Li YJ; Gao P; Ding PT; Xu H; Zheng JM
Yao Xue Xue Bao; 2003 Jun; 38(6):467-70. PubMed ID: 14513811
[TBL] [Abstract][Full Text] [Related]
34. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.
Ünal S; Doğan O; Aktaş Y
Beilstein J Nanotechnol; 2022; 13():1393-1407. PubMed ID: 36483636
[TBL] [Abstract][Full Text] [Related]
35. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines.
Alshetaili AS
Saudi J Biol Sci; 2021 Sep; 28(9):5065-5073. PubMed ID: 34466084
[TBL] [Abstract][Full Text] [Related]
36. Chitosan/PLGA shell nanoparticles as Tylotoin delivery platform for advanced wound healing.
Wang Y; Guo L; Liu J; Huang X; Wang X; Guo X; You X; Li W; Li L; Sun T; Gao Y
Int J Biol Macromol; 2022 Nov; 220():395-405. PubMed ID: 35934079
[TBL] [Abstract][Full Text] [Related]
37. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
38. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
40. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
